User profiles for Alok A. Khorana
 | Alok A. KhoranaHardis Endowed Chair in Onc Research, Vice-Chair, Taussig Cancer Ctr, Director, GI … Verified email at ccf.org Cited by 36893 |
Development and validation of a predictive model for chemotherapy-associated thrombosis
AA Khorana, NM Kuderer, E Culakova… - Blood, The Journal …, 2008 - ashpublications.org
Risk of venous thromboembolism (VTE) is elevated in cancer, but individual risk factors cannot
identify a sufficiently high-risk group of outpatients for thromboprophylaxis. We developed …
identify a sufficiently high-risk group of outpatients for thromboprophylaxis. We developed …
[PDF][PDF] American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer
GH Lyman, AA Khorana, A Falanga… - Journal of clinical …, 2007 - oncologycast.net
Purpose To develop guideline recommendations for the use of anticoagulation in the
prevention and treatment of venous thromboembolism (VTE) in patients with cancer. methods A …
prevention and treatment of venous thromboembolism (VTE) in patients with cancer. methods A …
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
AA Khorana, CW Francis, E Culakova… - … Journal of the …, 2007 - Wiley Online Library
BACKGROUND. Venous thromboembolism (VTE) contributes to morbidity and mortality in
cancer patients and is a frequent complication of anticancer therapy. In the current study, the …
cancer patients and is a frequent complication of anticancer therapy. In the current study, the …
[HTML][HTML] Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology
…, JO Hopkins, MC Janelsins, AA Khorana… - Journal of Clinical …, 2018 - ncbi.nlm.nih.gov
Purpose To provide guidance regarding the practical assessment and management of
vulnerabilities in older patients undergoing chemotherapy. Methods An Expert Panel was …
vulnerabilities in older patients undergoing chemotherapy. Methods An Expert Panel was …
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
Background: Venous thromboembolism (VTE) is a common complication among patients
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …
Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update
NS Key, AA Khorana, NM Kuderer, K Bohlke… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE To provide updated recommendations about prophylaxis and treatment of venous
thromboembolism (VTE) in patients with cancer. METHODS PubMed and the Cochrane …
thromboembolism (VTE) in patients with cancer. METHODS PubMed and the Cochrane …
[HTML][HTML] Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update 2014
GH Lyman, K Bohlke, AA Khorana… - Journal of Clinical …, 2015 - ncbi.nlm.nih.gov
Purpose To provide current recommendations about the prophylaxis and treatment of
venous thromboembolism (VTE) in patients with cancer. Methods PubMed and the Cochrane …
venous thromboembolism (VTE) in patients with cancer. Methods PubMed and the Cochrane …
[PDF][PDF] Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update
GH Lyman, AA Khorana, NM Kuderer… - Journal of Clinical …, 2013 - medvantageco.com
Purpose To provide recommendations about prophylaxis and treatment of venous
thromboembolism (VTE) in patients with cancer. Prophylaxis in the outpatient, inpatient, and …
thromboembolism (VTE) in patients with cancer. Prophylaxis in the outpatient, inpatient, and …
[HTML][HTML] Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer
AA Khorana, GA Soff, AK Kakkar… - … England Journal of …, 2019 - Mass Medical Soc
Background Ambulatory patients receiving systemic cancer therapy are at varying risk for
venous thromboembolism. However, the benefit of thromboprophylaxis in these patients is …
venous thromboembolism. However, the benefit of thromboprophylaxis in these patients is …
Cancer-associated venous thromboembolism
AA Khorana, N Mackman, A Falanga… - Nature reviews Disease …, 2022 - nature.com
Cancer-associated thrombosis (including venous thromboembolism (VTE) and arterial events)
is highly consequential for patients with cancer and is associated with worsened survival. …
is highly consequential for patients with cancer and is associated with worsened survival. …